CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 70 enrolled
Drug / intervention
10% Argirelinedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01381484
NCT01381484Phase 3Completed
CompareCT.gov

Efficacy and Safety of Topical Argireline in the Treatment of Periorbital Wrinkles

Mahidol University·interventional·Posted Jun 27, 2011·Updated Jun 27, 2011

In Brief

A Phase 3 clinical trial evaluating 10% Argireline for Wrinkles. Completed, enrolled 70 participants across 1 site.

Detailed Summary

The purpose of this study is to determine whether La Jolie gel is effective in the treatment of periorbital wrinkles.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsWrinkles
CountriesThailand
CollaboratorsPacific Health Foundation

Timeline

Phase 3CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedJun 27, 2011
Enrollment StartMar 1, 2009
Primary CompletionSep 1, 2009
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 15.0 years ago

Interventions

10% Argirelinedrug

10% Argireline (La jolie gel®, Pacific health care, Thailand) were instructed to apply the gel over the face and periorbital area twice daily for a period of 3 months.